Magnesium Sulfate

Magnesium Sulfate

Form: Intravenous (IV) / Intramuscular (IM) injection

Strength: 500 mg/mL (50%), 1 g/2 mL, 2 g/4 mL, 4 g/10 mL, 5 g/10 mL

Reference Brands: Magnesium Sulfate Injection(generics)

Category: Critical Care

Magnesium Sulfate is a critical electrolyte and anticonvulsant used in obstetrics for preeclampsia/eclampsia, as well as in managing arrhythmias and severe asthma. It is primarily available in IV/IM formulations with strengths ranging from 500 mg/mL (50%) to 5 g/10 mL. Leading manufacturers include Hospira, Fresenius Kabi, Hikma in the US, and B. Braun, Hameln, and Baxter in the EU. Magnesium Sulfate is a WHO-listed essential medicine, widely used in emergency and maternal health settings. Pharma B2B platforms support consistent bulk sourcing of Magnesium Sulfate injections for hospitals, ICUs, and critical care units globally.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details Get Enquiry
Insulin (IV)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details Get Enquiry
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details Get Enquiry
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

We use cookies to ensure you get the best experience. Learn more